|
|
|
|
| LEADER |
00959nam a2200265 u 4500 |
| 001 |
10041850 |
| 003 |
upatras |
| 005 |
20210117195951.0 |
| 008 |
011126s1986 eng |
| 020 |
|
|
|a 0930665082
|
| 040 |
|
|
|a GR-PaULI
|c GR-PaULI
|
| 041 |
0 |
|
|a eng
|
| 082 |
0 |
4 |
|a QV 4
|
| 100 |
1 |
|
|a Cooper, Glenn L.
|9 31067
|
| 245 |
1 |
0 |
|a Vancomycin
|b a comprehensive review of 30 year of clinical experience
|c Glenn L. Cooper , Douglas B. Given
|
| 260 |
|
|
|a [S.l.]
|b Eli Lilly and Company
|c 1986
|
| 300 |
|
|
|a 84 p.
|c 24 cm.
|
| 504 |
|
|
|a Includes index
|
| 650 |
|
4 |
|a Φαρμακολογία
|9 1400
|
| 700 |
1 |
|
|a Given, Douglas B.
|9 31068
|
| 852 |
|
|
|a GR-PaULI
|b ΠΑΤΡΑ
|b ΙΑΤΡΙΚΗ
|k ΑΣΧΞ-10
|h QV 4 COO
|m 1376
|p 025000008058
|t 1
|
| 942 |
|
|
|2 ddc
|c BK15
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 QV_4_000000000000000_COO
|7 0
|9 29521
|a MEDI
|b MEDI
|d 2016-04-24
|i 1376
|l 0
|o QV 4 COO
|p 025000008058
|r 2016-04-24 00:00:00
|t 1
|w 2016-04-24
|y BK15
|
| 998 |
|
|
|c MANIAKH
|d 2001-11
|
| 999 |
|
|
|c 18834
|d 18834
|
